We are live on
!
Find out more
VCG
Vantage Consulting Group Portfolio holdings
AUM
$19.7M
1-Year Est. Return
280.87%
This Fund
S&P 500
This Quarter
Est. Return
-4.74%
1 Year Est. Return
+280.87%
3 Year Est. Return
+261.08%
5 Year Est. Return
+180.34%
10 Year Est. Return
–
AUM
$11.4M
AUM Growth
-$123M
(-92%)
Cap. Flow
-$117M
Cap. Flow
% of AUM
-1,024.22%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
191
New
–
Increased
–
Reduced
–
Closed
187
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Syntax Stratified LargeCap ETF
SSPY
|
+$51.5M |
| 2 |
SMDY
Syntax Stratified MidCap ETF
SMDY
|
+$6.12M |
| 3 |
SSLY
Syntax Stratified SmallCap ETF
SSLY
|
+$3.05M |
| 4 |
ExxonMobil
XOM
|
+$738K |
| 5 |
Chevron
CVX
|
+$716K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 56.82% |
| 2 | Industrials | 43.18% |
| 3 | Consumer Staples | 0% |
| 4 | Energy | 0% |
| 5 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Babcock & Wilcox
BW
$1.39B
| $4.93M | 43.18% |
2,416,200
| – | – |
|
2
Cibus
CBUS
$147M
| $3.73M | 32.67% |
1,143,949
| – | – |
|
3
ADC Therapeutics
ADCT
$134M
| $2.68M | 23.47% |
850,737
| – | – |
|
|
KYNB
4
Kyntra Bio
KYNB
$27.2M
| $78.2K | 0.68% |
7,828
| – | – |
|
5
American Airlines Group
AAL
$10.1B
| – | – |
-15,494
| Closed | -$176K |
|
6
Apple
AAPL
$4.54T
| – | – |
-2,194
| Closed | -$462K |
|
7
AbbVie
ABBV
$443B
| – | – |
-1,379
| Closed | -$237K |
|
8
Analog Devices
ADI
$179B
| – | – |
-898
| Closed | -$205K |
|
9
Archer Daniels Midland
ADM
$38.2B
| – | – |
-5,877
| Closed | -$355K |
|
10
Automatic Data Processing
ADP
$106B
| – | – |
-858
| Closed | -$205K |
|
11
American Electric Power
AEP
$69.6B
| – | – |
-2,647
| Closed | -$232K |
|
12
AES
AES
$10.5B
| – | – |
-14,459
| Closed | -$254K |
|
13
American International
AIG
$41.7B
| – | – |
-3,174
| Closed | -$236K |
|
14
Assurant
AIZ
$13.8B
| – | – |
-1,408
| Closed | -$234K |
|
15
Akamai
AKAM
$16.7B
| – | – |
-2,792
| Closed | -$252K |
|
16
Allstate
ALL
$68B
| – | – |
-1,484
| Closed | -$237K |
|
17
Amcor
AMCR
$20.8B
| – | – |
-2,340
| Closed | -$114K |
|
18
Amgen
AMGN
$208B
| – | – |
-785
| Closed | -$245K |
|
19
Aptiv
APTV
$12B
| – | – |
-4,968
| Closed | -$350K |
|
20
Atmos Energy
ATO
$28.8B
| – | – |
-2,674
| Closed | -$312K |
|
21
American Water Works
AWK
$26.7B
| – | – |
-2,404
| Closed | -$311K |
|
22
Brown-Forman Class B
BF.B
$13.2B
| – | – |
-5,336
| Closed | -$230K |
|
23
Bunge Global
BG
$20.4B
| – | – |
-3,394
| Closed | -$362K |
|
24
Biogen
BIIB
$30B
| – | – |
-1,005
| Closed | -$233K |
|
25
Baker Hughes
BKR
$60B
| – | – |
-9,996
| Closed | -$352K |
|
Similar funds
MVG
NCM
FFGIM
PIM
HFG
SWM
ICM
SM
Vantage Consulting Group's Q3 2024 Portfolio in Review
As of Q3 2024, Vantage Consulting Group held 191 positions worth $11.4M, down 92% from $135M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Vantage Consulting Group withdrew a net $117M in Q3 2024, closing 187 positions. Its most notable exit was Syntax Stratified LargeCap ETF, an estimated $51.5M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 57% of assets, up from 15% a quarter earlier, followed by Industrials and Consumer Staples.
- Vantage Consulting Group fully exited Syntax Stratified LargeCap ETF in Q3 2024, selling an estimated $51.5M.
- Vantage Consulting Group's ten largest holdings make up 100% of its $11.4M portfolio in Q3 2024.
- Vantage Consulting Group opened 0 new positions and closed 187 in Q3 2024.
- Vantage Consulting Group's portfolio value fell 92% quarter-over-quarter to $11.4M.
Based on Vantage Consulting Group's 13F filing for Q3 2024, filed 14 Nov 2024.